Clinical Trial Update: The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC) [Phase 3]

View source ↗

Summary

A Phase 3 adjuvant breast cancer trial compares UFT plus tamoxifen versus CMF plus tamoxifen; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• FLUOROURACIL (Fluorouracil)
• METHOTREXATE (METHOTREXATE)
• Tamoxifen (tamoxifen)
• UFT (tegafur-uracil)

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED